Stanford TAVR Program
Minimally-invasive, catheter-based therapy
Room A260 300 Pasteur Drive
Stanford, CA 94305
Providing Needed Relief for Patients with Aortic Stenosis
Transcatheter aortic valve replacement (TAVR) is a less invasive procedure used to treat patients with severe aortic stenosis who are at increased risk for traditional surgical aortic valve replacement. Aortic stenosis causes a narrowing of the aortic valve which makes it more difficult for the heart to pump blood.
The TAVR procedure enables the delivery of an artificial heart valve, through a small incision, using a catheter-based approach. The new valve functions like a normal heart valve, improves blood flow, and reduces symptoms caused by aortic stenosis. Stanford is one of only three hospitals in Northern California that performs this procedure.
New Device, Hybrid Team Restore Ailing Heart Valves Once Inoperable
Stanford patient Gary Verwer was diagnosed with severe aortic stenosis, but due to a bypass surgery years earlier he was not eligible for open surgical valve replacement. Verwer instead underwent a new, less invasive procedure as part of a clinical trial, called transcatheter aortic valve replacement or TAVR. |
Meet Our Team
-
Rajesh Dash, MD
Assistant Professor, Cardiovascular Medicine
-
William F. Fearon, MD
Associate Director, Interventional Cardiology; Associate Professor, Cardiovascular Medicine
-
Michael P. Fischbein, MD, PhD
Assistant Professor, Cardiothoracic Surgery
-
Charles C. Hill, MD
Clinical Assistant Professor, Anesthesia
-
David H. Liang, MD, PhD
Associate Professor, Cardiovascular Medicine
-
Cheryl McWard, RN
Clinical Nurse Coordinator
-
D. Craig Miller, MD
Professor, Cardiothoracic Surgery
-
Patrick David Soran, MD
Clinical Assistant Professor, Anesthesia
-
Martina Speight, RN, MSN
Clinical Nurse Coordinator
-
Pieter van der Starre, MD, PhD
Professor, Anesthesia
-
Alan C. Yeung, MD
Director, Interventional Cardiology; Chief, Division of Cardiovascular Medicine (Clinical); Clinical Director, Cardiovascular Institute